Skip to main content

Detection of Hepatitis B Virus X Antigen by Immunohistochemistry and Western Blotting

  • Protocol
Book cover Hepatitis B and D Protocols

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 95))

Abstract

The genome of hepatitis B virus (HBV) is a partially double-stranded DNA molecule within virus particles that is approx 3.2 kbp long (1,2). It has four open reading frames, all on one strand, that encode the surface antigen or envelope polypeptides, core or nucleocapsid polypeptide, the viral polymerase, and the so-called “X” protein (1,2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P., and Charnay, P. (1979) Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281, 646–650.

    Article  PubMed  CAS  Google Scholar 

  2. Valenzuela, P., Quiroga, M., Zaldivar, J., Gray, P., and Rutter, W. J. (1980) The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. In: Fields, B. N., Jaenisch, R., and Fox, C. F. (eds.), Animal Virus Genetics, Academic Press, New York, 57–70.

    Google Scholar 

  3. Bayer, M. E., Blumberg, B. S., and Werner, B. (1968) Particles associated with Australia antigen in sera of patients with leukemia, Down’s syndrome and hepatitis. Nature 218, 1057–1059.

    Article  PubMed  CAS  Google Scholar 

  4. Dane, D. S., Cameron, C. H., and Briggs, M. (1970) Virus-like particles in serum of patients with Australia antigen-associated hepatitis. Lancet 2, 695–698.

    Article  Google Scholar 

  5. Almeida, J. D., Rubenstein, D., and Stott, E. J. (1971) New antigen-antibody system in Australia antigen-positive hepatitis. Lancet 2, 1225–1227.

    Article  PubMed  CAS  Google Scholar 

  6. Budkowska, A. (1977) Immunochemical and morphological studies of hepatitis B core antigen isolated from the nuclei of hepatocytes. J. Infect. Dis. 135, 463–467.

    PubMed  CAS  Google Scholar 

  7. Maynard, J. E., Barret, D. H., Murphy, B. L., Bradley, D. W., Berquist, K. R., and Bender T. R. (1976) Relation of e antigen to hepatitis B virus infection in an area of hyperendemicity. J. Infect. Dis. 133, 339–342.

    PubMed  CAS  Google Scholar 

  8. Okado, K., Kamiyama, I., Inomata, M., Imai, M., Miyakawa, Y., and Mayumi, M. (1976) e Antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N. Engl. J. Med. 294, 746–749.

    Article  Google Scholar 

  9. Bavand, M., Feitelson, M., and Laub, O. (1989) The hepatitis B virus-associated reverse transcriptase is encoded by the viral pol gene. J. Virol. 63, 1019–1021.

    PubMed  CAS  Google Scholar 

  10. Oberhaus, S. M., and Newbold, J. E. (1993) Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay. J. Virol. 67, 6558–6566.

    PubMed  CAS  Google Scholar 

  11. Radziwill, G., Tucker, W., and Schaller, H. (1990) Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J. Virol. 64, 613–620.

    PubMed  CAS  Google Scholar 

  12. Summers, J., and Mason, W. (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29, 403–415.

    Article  PubMed  CAS  Google Scholar 

  13. Bartenschlager, R., and Schaller, H. (1988) The amino-terminal domain of the hepadnavirus P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J. 7, 4185–4192.

    PubMed  CAS  Google Scholar 

  14. Rossner, M. T. (1992) Hepatitis B virus X-gene product: a promiscuous transcriptional activator. J. Med. Virol. 36, 101–117.

    Article  PubMed  CAS  Google Scholar 

  15. Nakatake, H., Chisaka, O., Yamamoto, S., Matsubara, K., and Koshy, R. (1993) Effect of X protein on transactivation of HBV promoters and on viral replication. Virology 195, 305–314.

    Article  PubMed  CAS  Google Scholar 

  16. Colgrove, R., Simon, G., and Ganem, D. (1989) Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J. Virol. 63, 4019–4026.

    PubMed  CAS  Google Scholar 

  17. Chen, H. S., Kaneko, S., Girones, R., et al. (1993) The WHV X gene is important for establishment of virus infection in woodchucks. J. Virol. 67, 1218–1226.

    PubMed  CAS  Google Scholar 

  18. Zoulim, F., Saputelli, J., and Seeger, C. (1994) Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68, 2026–2030.

    PubMed  CAS  Google Scholar 

  19. Henkler, F., and Koshy, R. (1996) Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. J. Vi ral Hepat. 3, 109–121.

    CAS  Google Scholar 

  20. Arbuthnot, P., Capovilla, A., and Kew, M. (2000) Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J. Gastroenterol. Hepatol. 15, 357–368.

    Article  PubMed  CAS  Google Scholar 

  21. Beasley, R. P., Hwang, L. Y., Lin, C. C., and Chien, C. S. (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2, 1129–1133.

    Article  PubMed  CAS  Google Scholar 

  22. Beasley, R. P., and Hwang, L. Y. (1994) Epidemiology of hepatocellular carcinoma. In: Vyas, G. N., Dienstag, J. L., and Hoofnagle, J. H. (eds.), Viral Hepatitis and Liver Disease, Grune and Stratton, New York, 209–224.

    Google Scholar 

  23. Maddrey, W. C. (2001) Hepatitis B—an important public health issue. Clinica y Laboratorio 47, 51–55.

    CAS  Google Scholar 

  24. Lok, A. S., Heathcote, E. J., and Hoofnagle, J. H. (2001) Management of hepatitis B: 2000—summary of a workshop. Gastroenterology 120, 1828–1853.

    Article  PubMed  CAS  Google Scholar 

  25. Hilleman, M. R. (2001) Overview of the pathogenesis, prophylaxis and therapeutics of viral hepatitis B, with focus on reduction to practical applications. Vaccine 19, 1837–1848.

    Article  PubMed  CAS  Google Scholar 

  26. Moriarty, A. M., Alexander, H., and Lerner, R. A. (1985) Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 227, 429–433.

    Article  PubMed  CAS  Google Scholar 

  27. Schek, N., Bartenschlager, R., Kuhn, C., and Schaller, H. (1991) Phosphorylation and rapid turnover of hepatitis B virus X protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 6, 1735–1744.

    PubMed  CAS  Google Scholar 

  28. Levrero, M., Jean-Jean, O., Balsano, C., Will, H., and Perricaudet, M. (1990) Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection. Virology 174, 299–304.

    Article  PubMed  CAS  Google Scholar 

  29. Ke-qin, H., Jian-jie, H., and Will, H. (1988) A preliminary study on localization of HBxAg in liver tissue of patients with chronic liver disease and its significance. Chinese Med. J. 101, 671–674.

    Google Scholar 

  30. Vitvitski-Trepo, L., Kay, A., Pichoud, C., et al. (1990) Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection. Hepatology 12, 1278–1283.

    Article  PubMed  CAS  Google Scholar 

  31. Levrero, M., Jean-Jean, O., Balsano, C., Will, H., and Perricaudet, M. (1987) Hepatitis B virus (HBV) X gene expression in human cells and anti-x antibodies detection in chronic HBV infection. In: Robinson, W. S., Koike, K., and Will, H. (eds.), Hepadna Viruses, Alan R. Liss, New York, 237–252.

    Google Scholar 

  32. Pfaff, E., Salfeld, J., Gmelin, K., Schaller, H., and Theilmann, L. (1987) Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology 158, 456–460.

    Article  PubMed  CAS  Google Scholar 

  33. Haruna, Y., Hayashi, N., Katayama, K., et al. (1991) Expression of X protein and hepatitis B virus replication in chronic hepatitis. Hepatology 13, 417–421.

    Article  PubMed  CAS  Google Scholar 

  34. Suzuki, K., Uchida, T., Shikata, T., et al. (1990) Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B. Liver 10, 355–364.

    PubMed  CAS  Google Scholar 

  35. Feitelson, M. A., and Clayton, M. M. (1990) The X antigen/antibody markers in hepadnavirus infections. II. Antibodies to the X gene product(s). Gastroenterology 99, 500–507.

    PubMed  CAS  Google Scholar 

  36. Feitelson, M. A., and Clayton, M. M. (1990) X antigen polypeptides in the sera of hepatitis B virus infected patients. Virology 177, 367–371.

    Article  PubMed  CAS  Google Scholar 

  37. Feitelson, M. A., Clayton, M. M., and Blumberg, B. S. (1990) The X antigen/antibody markers in hepadnavirus infections. I. Presence and significance of the hepadnavirus X gene product(s) in serum. Gastroenterology 98, 1071–1078.

    PubMed  CAS  Google Scholar 

  38. Vitvitski, L., Meyers, M. L., Sninsky, J. J., et al. (1988) Expression of the X gene product of hepatitis B virus and WHV in infected livers and transfected 3T3 cells: evidence for cross-reactivity and correlation with core/e gene expression. In: Zuckerman, A. J. (ed.), Vira l Hepatitis and Liver Disease, Alan R. Liss, New York, 341–344.

    Google Scholar 

  39. Katayama, K., Hayashi, N., Sasaki, Y., et al. (1989) Detection of hepatitis B virus X gene protein and antibody in type B chronic liver disease. Gastroenterology 97, 990–998.

    PubMed  CAS  Google Scholar 

  40. Zentgraf, H., Herrmann, G., Klein, R., et al. (1990) Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology 47, 143–148.

    Article  PubMed  CAS  Google Scholar 

  41. Takeuchi, M., Fujimoto, J., Niwamoto, H., Yamamoto, Y., and Okamoto, E. (1997) Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients. Dig. Dis. Sci. 42, 2264–2269.

    Article  PubMed  CAS  Google Scholar 

  42. Diamantis, I. D., McGandy, C. E., Chen, T. J., Liaw, Y. F., Gudat, F., and Bianchi, L. (1992) Hepatitis B X-gene expression in hepatocellular carcinoma. J. Hepatol. 15, 400–403.

    Article  PubMed  CAS  Google Scholar 

  43. Poussin, K., Dienes, H., Sirma, H., et al. (1999) Expression of mutated hepatitis B virus X genes in human hepatocellular carcinoma. Int. J. Cancer 80, 497–505.

    Article  PubMed  CAS  Google Scholar 

  44. Schluter, V., Meyer, M., Hofschneider, P. H., Koshy, R., and Caselmann, W. H. (1994) Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene 9, 3335–3344.

    PubMed  CAS  Google Scholar 

  45. Wang, W., London, W. T., Lega, L., and Feitelson, M. A. (1991) Hepatitis B x antigen in liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14, 29–37.

    Article  PubMed  CAS  Google Scholar 

  46. Wang, W., London, W. T., and Feitelson, M. A. (1991) Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res. 51, 4971–4977.

    PubMed  CAS  Google Scholar 

  47. Feitelson, M. A., Lega, L., Duan, L.-X., and Clayton, M. (1993) Characteristics of wood-chuck hepatitis X antigen in the livers and sera from chronically infected animals. J. Hepatol. 17, S24–S34.

    Article  PubMed  CAS  Google Scholar 

  48. Su, Q., Schroder, C. H., Hofmann, W. J., Otto, G., Pichlmayr, R., and Bannasch, P. (1998) Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27, 1109–1120.

    Article  PubMed  CAS  Google Scholar 

  49. Kim, H., Lee, H., and Yun, Y. (1998) X-gene product of hepatitis B virus induces apoptosis in liver cells. J. Biol. Chem. 273, 381–385.

    Article  PubMed  CAS  Google Scholar 

  50. Pollicino, T., Terradillos, O., Lecoeur, H., Gougeon, M. L., and Buendia, M. A. (1998) Pro-apoptotic effect of the hepatitis B virus X gene. Biomed. Pharmacother. 52, 363–368.

    Article  PubMed  CAS  Google Scholar 

  51. Shirakata, Y., Kawada, M., Fujiki, Y., et al. (1989) The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn. J. Cancer Res. 80, 617–621.

    PubMed  CAS  Google Scholar 

  52. Jameel, S., Siddiqui, A., Maguire, H. F., and Rao, K. V. S. (1990) Hepatitis B virus protein produced in Escherichia coli is biologically functional. J. Virol. 64, 3963–3966.

    PubMed  CAS  Google Scholar 

  53. Takada, S., Kaneniwa, N., Tsuchida, N., and Koike, K. (1997) Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene transfected cells. Oncogene 15, 1895–1901.

    Article  PubMed  CAS  Google Scholar 

  54. Kuzhandaivelu, N., Cong, Y. S., Inouye, C., Yang, W. M., and Seto E. (1996) XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res. 24, 4741–4750.

    Article  PubMed  CAS  Google Scholar 

  55. Becker, S. A., Lee, T. H., Butel, J. S., and Slagle, B. L. (1998) Hepatitis B virus protein interferes with cellular DNA repair. J. Virol. 72, 266–272.

    PubMed  CAS  Google Scholar 

  56. Shintani, Y., Yotsuyanagi, H., Moriya, K., et al. (1999) Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system. J. Gen. Virol. 80, 3257–3265.

    PubMed  CAS  Google Scholar 

  57. Lee, Y. H., and Yun, Y. (1998) HBx protein of hepatitis B virus activates Jak1-STAT signaling. J. Biol. Chem. 273, 25,510–25,515.

    Article  PubMed  CAS  Google Scholar 

  58. Lian, Z., Pan, J., Liu, J., et al. (1999) The translation initiation factor, SUI1, may be a target of hepatitis B x antigen in hepatocarcinogenesis. Oncogene 18, 1677–1687.

    Article  PubMed  CAS  Google Scholar 

  59. Su, F., and Schneider, R. J. (1997) Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 94, 8744–8749.

    Article  PubMed  CAS  Google Scholar 

  60. Blum, H. E., Zhang, Z. S., Galun, E., et al. (1992) Hepatitis B virus X protein is not central to the viral life cycle in vitro. J. Virol. 66, 1223–1227.

    PubMed  CAS  Google Scholar 

  61. Shin, E. C., Shin, J. S., Park, J. H., Kim, H., and Kim, S. J. (1999) Expression of Fas ligand in human hepatoma cell lines: role of hepatitis B virus X (HBx) in induction of Fas ligand. Int. J. Cancer 82, 587–591.

    Article  PubMed  CAS  Google Scholar 

  62. Lara-Pezzi, E., Majano, P. L., Gomez-Gonzalo, M., et al. (1998) The hepatitis B virus X protein up-regulates tumor necrosis factor a gene expression in hepatocytes. Hepatology 28, 1013–1028.

    Article  PubMed  CAS  Google Scholar 

  63. Doong, S. L., Lin, M. H., Tsai, M. M., Li, T. R., Chuang, S. E., and Cheng, A. L. (1998) Transactivation of the human MDR1 gene by hepatitis B virus X gene product. J. Hepatol. 29, 872–878.

    Article  PubMed  CAS  Google Scholar 

  64. Ueda, H., Ullrich, S. J., Ngo, L., et al. (1995) Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet. 9, 41–47.

    Article  PubMed  CAS  Google Scholar 

  65. Koike, K, Moriya, K, Iino, S., et al. (1994) High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19, 810–819.

    Article  PubMed  CAS  Google Scholar 

  66. Schmitteckert, E. M., and Schlicht, H. J. (1999) Detection of the human hepatitis B virus X-protein in transgenic mice after radioactive labeling at a newly introduced phosphorylation site. J. Gen. Virol. 80, 2501–2509.

    PubMed  CAS  Google Scholar 

  67. Slagle, B. L., Lee, T. H., Medina, D., Finegold, M. J., and Butel, J. S. (1996) Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinog. 15, 261–269.

    Article  PubMed  CAS  Google Scholar 

  68. Lee, T. H., Finegold, M. J., Shen, R. F., DeMayo, J. L., Woo, S. L., and Butel, J. S. (1990) Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J. Virol. 64, 5939–5947.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc.

About this protocol

Cite this protocol

Liu, J., Feitelson, M.A. (2004). Detection of Hepatitis B Virus X Antigen by Immunohistochemistry and Western Blotting. In: Hamatake, R.K., Lau, J.Y.N. (eds) Hepatitis B and D Protocols. Methods in Molecular Medicine, vol 95. Humana Press. https://doi.org/10.1385/1-59259-669-X:71

Download citation

  • DOI: https://doi.org/10.1385/1-59259-669-X:71

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-105-9

  • Online ISBN: 978-1-59259-669-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics